These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24040824)

  • 1. Synaptic dysfunction in synucleinopathies.
    Anichtchik O; Calo L; Spillantini MG
    CNS Neurol Disord Drug Targets; 2013 Dec; 12(8):1094-100. PubMed ID: 24040824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of α-synuclein in neurotransmission and synaptic plasticity.
    Cheng F; Vivacqua G; Yu S
    J Chem Neuroanat; 2011 Dec; 42(4):242-8. PubMed ID: 21167933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The paradoxical cell biology of alpha-Synucle.
    Roy S
    Results Probl Cell Differ; 2009; 48():159-72. PubMed ID: 19582404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein aggregation mechanisms in synucleinopathies: commonalities and differences.
    Beyer K; Ariza A
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):965-74. PubMed ID: 17984679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease?
    Schulz-Schaeffer WJ
    Biomolecules; 2015 Jul; 5(3):1467-79. PubMed ID: 26193328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptic failure and α-synuclein.
    Calo L; Wegrzynowicz M; Santivañez-Perez J; Grazia Spillantini M
    Mov Disord; 2016 Feb; 31(2):169-77. PubMed ID: 26790375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropathological spectrum of synucleinopathies.
    Jellinger KA
    Mov Disord; 2003 Sep; 18 Suppl 6():S2-12. PubMed ID: 14502650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-synuclein and transgenic mouse models.
    Fernagut PO; Chesselet MF
    Neurobiol Dis; 2004 Nov; 17(2):123-30. PubMed ID: 15474350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p25alpha Stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies.
    Lindersson E; Lundvig D; Petersen C; Madsen P; Nyengaard JR; Højrup P; Moos T; Otzen D; Gai WP; Blumbergs PC; Jensen PH
    J Biol Chem; 2005 Feb; 280(7):5703-15. PubMed ID: 15590652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurons and Glia Interplay in α-Synucleinopathies.
    Mavroeidi P; Xilouri M
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synucleins in synaptic plasticity and neurodegenerative disorders.
    Clayton DF; George JM
    J Neurosci Res; 1999 Oct; 58(1):120-9. PubMed ID: 10491577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-synuclein: its biological function and role in neurodegenerative diseases.
    Kaplan B; Ratner V; Haas E
    J Mol Neurosci; 2003 Apr; 20(2):83-92. PubMed ID: 12794302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies.
    Villar-Piqué A; Lopes da Fonseca T; Outeiro TF
    J Neurochem; 2016 Oct; 139 Suppl 1():240-255. PubMed ID: 26190401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies.
    Peng C; Gathagan RJ; Lee VM
    Neurobiol Dis; 2018 Jan; 109(Pt B):209-218. PubMed ID: 28751258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-synuclein: between synaptic function and dysfunction.
    Di Rosa G; Puzzo D; Sant'Angelo A; Trinchese F; Arancio O
    Histol Histopathol; 2003 Oct; 18(4):1257-66. PubMed ID: 12973692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic RNAi screen reveals involvement of endocytic pathway in neuronal dysfunction in alpha-synuclein transgenic C. elegans.
    Kuwahara T; Koyama A; Koyama S; Yoshina S; Ren CH; Kato T; Mitani S; Iwatsubo T
    Hum Mol Genet; 2008 Oct; 17(19):2997-3009. PubMed ID: 18617532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-synuclein misfolding and neurodegenerative diseases.
    Uversky VN
    Curr Protein Pept Sci; 2008 Oct; 9(5):507-40. PubMed ID: 18855701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies.
    Vicente Miranda H; Szego ÉM; Oliveira LMA; Breda C; Darendelioglu E; de Oliveira RM; Ferreira DG; Gomes MA; Rott R; Oliveira M; Munari F; Enguita FJ; Simões T; Rodrigues EF; Heinrich M; Martins IC; Zamolo I; Riess O; Cordeiro C; Ponces-Freire A; Lashuel HA; Santos NC; Lopes LV; Xiang W; Jovin TM; Penque D; Engelender S; Zweckstetter M; Klucken J; Giorgini F; Quintas A; Outeiro TF
    Brain; 2017 May; 140(5):1399-1419. PubMed ID: 28398476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein trapping leads to altered synaptic proteostasis in synucleinopathies.
    Santos PI; Outeiro TF
    FEBS J; 2020 Dec; 287(24):5294-5303. PubMed ID: 32400966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensing α-Synuclein From the Outside via the Prion Protein: Implications for Neurodegeneration.
    Brás IC; Lopes LV; Outeiro TF
    Mov Disord; 2018 Nov; 33(11):1675-1684. PubMed ID: 30423195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.